Parabilis Medicines Q3 EPS $(0.36), Inline, Sales $2.114M Beat $375.000K Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings Beats
Parabilis Medicines (NASDAQ:PBLS) reported quarterly losses of $(0.36) per share which met the analyst consensus estimate. This is a 98.34 percent increase over losses of $(21.66) per share from the same period last
Parabilis Medicines (NASDAQ:PBLS) reported quarterly losses of $(0.36) per share which met the analyst consensus estimate. This is a 98.34 percent increase over losses of $(21.66) per share from the same period last year. The company reported quarterly sales of $2.114 million which beat the analyst consensus estimate of $375.000 thousand by 463.73 percent.